Literature DB >> 24065687

Effect of atorvastatin on left atrial function of patients with paroxysmal atrial fibrillation.

Y D Li1, B P Tang, F Guo, J X Li, W Han, Q Tang, Y Y Zhang.   

Abstract

The aim of this study was to evaluate the effects of atorvastatin on left atrial (LA) function in paroxysmal atrial fibrillation patients. Fifty-eight paroxysmal atrial fibrillation patients were divided into two groups (treatment and control groups). The echocardiography parameters, including LA active emptying volume (LAAEV), LA active emptying fraction, LA maximum volume, LA total emptying volume, LA total emptying fraction, and LA ejection force (LAEF), were measured before treatment, and then 12 and 18 months after treatment. Compared to pre-treatment levels, the parameters reflecting LA pump function, such as LAAEV and LAEF, decreased significantly in treatment groups 12 months after treatment (P < 0.05). LAAEV and LAEF significantly increased 18 months after treatment (P < 0.05), and the indicators reflecting LA reservoir function, such as maximum volume, total emptying volume, and total emptying fraction increased significantly 18 months after treatment (P < 0.05). Compared with pre-treatment levels, LAAEV and LAEF decreased significantly 18 months after treatment in the control group (P < 0.05). These results demonstrated that long-term atorvastatin treatment could ameliorate the function of the atrium sinistrum.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24065687     DOI: 10.4238/2013.September.10.5

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  5 in total

Review 1.  Non-Alcoholic Fatty Liver Disease and Cardiovascular Comorbidities: Pathophysiological Links, Diagnosis, and Therapeutic Management.

Authors:  Alexandra Jichitu; Simona Bungau; Ana Maria Alexandra Stanescu; Cosmin Mihai Vesa; Mirela Marioara Toma; Cristiana Bustea; Stela Iurciuc; Marius Rus; Nicolae Bacalbasa; Camelia Cristina Diaconu
Journal:  Diagnostics (Basel)       Date:  2021-04-12

Review 2.  Epicardial Adipose Tissue and Cardiac Arrhythmias: Focus on Atrial Fibrillation.

Authors:  Maddalena Conte; Laura Petraglia; Serena Cabaro; Vincenza Valerio; Paolo Poggio; Emanuele Pilato; Emilio Attena; Vincenzo Russo; Adele Ferro; Pietro Formisano; Dario Leosco; Valentina Parisi
Journal:  Front Cardiovasc Med       Date:  2022-06-30

3.  Atorvastatin Treatment for Atrial Fibrillation Reduces Serum High-Sensitivity C-Reactive Protein Levels.

Authors:  Fang-Cheng Su; Xi-Dong Li; Shao-Xia Sun; Ming-Yu Shi; Feng-Hua Xue; Shi-Chao Teng; Li Jiang; Jing Zhu; Feng Yin; Hong-Yue Gu
Journal:  Biomed Res Int       Date:  2015-07-01       Impact factor: 3.411

Review 4.  Potential Role of Atrial Myopathy in the Pathogenesis of Stroke in Rheumatoid Arthritis and Psoriasis: A Conceptual Framework and Implications for Prophylaxis.

Authors:  Milton Packer
Journal:  J Am Heart Assoc       Date:  2020-01-24       Impact factor: 5.501

Review 5.  Role of Epicardial Adipose Tissue in Cardiovascular Diseases: A Review.

Authors:  Michał Konwerski; Aleksandra Gąsecka; Grzegorz Opolski; Marcin Grabowski; Tomasz Mazurek
Journal:  Biology (Basel)       Date:  2022-02-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.